University of Wollongong
Browse

Epi-croomine and croomine from Stemona tuberosa antimalarial drug for inhibiting dihydrofolate reductase (DHFR) activity and their molecular modeling

Download (397.35 kB)
journal contribution
posted on 2024-11-18, 18:02 authored by Pratiwi Pudjiastuti, Sri Sumarsih, Heny Arwati, Ilma Amalina, Much Z Fanani, Edi P Utomo, Loeki E Fitri, Ari Satia NugrahaAri Satia Nugraha, Wilford LieWilford Lie, Stephen PyneStephen Pyne
One of the mechanism actions of antimalarial drugsis by an inhibiting on the enzyme dihydrofolate reductase (DHFR), an enzyme target antifolate drug. Epi-croomine and croomine, are alkaloids isolated from Stemonatuberosa showed DHFR inhibition with Ki of 61.14 and 100.59 μM and KM values of30.68 and 27.06 μM at 10 ppm. The IC50 to the DHFR of croomine and pyrimethamine were 5.29 and 7.71 μM, respectively. Tuberostemonine is not active to the enzyme. The kinetic analysis showed that both epi-croomine and croomine competitively inhibited to the human DHFR recombinant. The molecular modeling of the compounds to the human DHFR was estimate depi-croomine and croomine's binding free energy of -6.66 and -7.60 kcal/mol. The docking showed that both epi-croomine and croomine could possibly form hydrogen bonds with the amino acid residue of theAla9, which residues on the active site of the enzyme.

History

Citation

Pudjiastuti, P., Sumarsih, S., Arwati, H., Amalina, I., Fanani, M. Z., Utomo, E. P., Fitri, L., Nugraha, A. S., Lie, W. & Pyne, S. G. (2014). Epi-croomine and croomine from Stemona tuberosa antimalarial drug for inhibiting dihydrofolate reductase (DHFR) activity and their molecular modeling. Journal of Chemical and Pharmaceutical Research, 6 (6), 544-548.

Journal title

Journal of Chemical and Pharmaceutical Research

Volume

6

Issue

6

Pagination

544-548

Language

English

RIS ID

91737

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC